✦
UWELL CLOUD YOU JIAN YUN

Pan-Tumor DC Vaccine

泛肿瘤治疗

Dendritic cells help present antigens to the immune system. A dendritic-cell cancer vaccine is intended to direct an immune response against selected cancer-related antigens. The antigen source and manufacturing process are central to identifying the actual product.

Worker in protective clothing in a West China Lecheng Hospital laboratory
Hospital setting · Image credits

Explore LK101 personalized cancer vaccine and research pipeline

Hospital named in the catalogue

West China Hospital International Medical Center Accredited National Medical Center / Public
About this guide

Clinical details below are in English. Ask the care team for help understanding the source documents.

What to clarify

How assessment and planning work

For this catalogue entry, the next useful document is a specification covering: tumour antigen selection, cell preparation and product-specific evidence. The receiving clinician should connect those details to the patient’s actual concern before suggesting tests, a schedule or travel.

Before your consultation

Histology, tumour stage, molecular tests, treatment history and the proposed vaccine documentation.

Send existing records for an initial discussion. Do not arrange new tests, change medication or book non-refundable travel solely from this page. The receiving team should state which additional information is actually needed.

Evidence and limitations

The material available for this named programme does not support a product-specific safety or effectiveness assessment. Possible interactions and procedure risks depend on what is actually supplied. A written product or protocol and the applicable clinical or research pathway are therefore required.

Questions to ask

Is a cancer treatment vaccine the same as a preventive vaccine?

No. NCI distinguishes vaccines intended to treat an existing cancer from vaccination that prevents infection. A dendritic-cell proposal needs a tumour-specific rationale and a clearly identified clinical or research pathway.

What should be included in my written treatment plan?

The treating team should identify the proposed intervention, alternatives, relevant uncertainty, clinical eligibility, anticipated visits, monitoring and arrangements if the plan changes after assessment. Ask who is responsible for follow-up after you return home.

Price and quotation

Ask for an itemized provider quotation after the clinical team reviews your records. The scope may depend on the exact intervention, investigations, consumables, admission and monitoring. Confirm currency, validity period and what happens if the plan changes. Medical fees are paid directly to the provider; Uwell coordination is separate.

Reference catalogue

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Sariyah Ahmad
Active Triage Officer

Welcome to Uwell Cloud. Connecting from Malaysia, Indonesia, or Thailand? Ask me about visa-free travel and stem cell medical programs in Boao Lecheng.